1. Dib BN, Zash R, Brummel S, Diseko M, et al.
   Antiretroviral therapy regimens initiated during pregnancy and risks of adverse perinatal outcomes.
   AIDS 2026.
   


2. Budu MO, Kooij KW, Dhinsa R, McLinden T, et al.
   Does where you live matter? Rurality and 30-day hospital readmission among people with HIV.
   AIDS 2026.
   


3. Choc-Cano X, Pelayo-Madrigal M, Gutierrez-Maya E, Zepeda-Quiroz I, et al.
   Clinical Factors Associated with Short-Term Decline in Estimated Glomerular Filtration Rate in People Living with HIV Receiving Antiretroviral Therapy: A Prospective Cohort Study.
   AIDS Res Hum Retroviruses 2026.
   


4. Moody K, Vanbellinghen MC, Nieuwkerk PT, Boyd A, et al.
   In people with HIV frailty is associated with worse health-related quality of life: results from the AGEhIV study.
   Clin Infect Dis 2026.
   


5. Fallon SM, Zuniga-Moya JC, Rauseo A, de Oliveira Santana MA, et al.
   Histoplasma Capsulatum Antigen Persistence and Rate of Decay During Treatment of Histoplasmosis Varies by Immune Status.
   Clin Infect Dis 2026.
   


6. Nakamura H, Yamamoto K.
   Small Mean Differences May Hide a Vulnerable Subgroup: Frailty and Quality of Life in Aging People With HIV.
   Clin Infect Dis 2026.
   


7. Schnarrs PW, Nash P, Ruderman SA, Crane HM, et al.
   The Impact of Childhood Household Violence on HIV-Related Outcomes in People with HIV in the United States: The Role of Psychological Distress and Social Stressors: Erratum.
   J Acquir Immune Defic Syndr 2026;101:e36.
   


8. Oliveira VH, Dos Santos AP, Davey CH, Schexnayder JK, et al.
   Moderate-to-Vigorous Physical Activity, Muscle Function, and Contemporary Sarcopenia Definitions in Older Adults With HIV.
   J Acquir Immune Defic Syndr 2026.
   


9. Navarro-Soler R, Heise MJ, Dalhuisen T, Grebe H, et al.
   CD4 Count and CD4/CD8 Ratio Impact Antibody Responses to COVID-19 mRNA Booster Vaccination in People with HIV on Suppressive ART.
   J Acquir Immune Defic Syndr 2026.
   


10. Wu L, Anderson PL, MaWhinney S, Saina M, et al.
    Effect of Pregnancy on Intracellular Tenofovir Diphosphate Exposure and Thresholds following Oral Emtricitabine-Tenofovir Disoproxil fumarate Pre-Exposure Prophylaxis: A Directly Observed Dosing Study.
    J Infect Dis 2026.
    


11. Bai H, Juraska M, Magaret CA, Yssel A, et al.
    VRC01 exerted differential pressure on HIV-1 Env from subtypes B and C that continued in the first weeks post-diagnosis in the AMP trials.
    J Infect Dis 2026.
    


12. Nogueira BMF, Vinhaes CL, Rangel FA, Fukutani ER, et al.
    Hyperinflammatory Profiles and Early Mortality in HIV-Associated Tuberculosis: A Prospective Cohort Study in Brazil.
    J Infect Dis 2026.
    


13. Boujamline S, Boschi C, Bes-Barlandier H, Tomei C, et al.
    Real-World Experience With Lenacapavir and/or Fostemsavir as Emerging Therapies for the Management of Multidrug-Resistant HIV-1 in Southeastern France.
    J Med Virol 2026;98:e71149.
    


14. Abyar S, Mohebbi SR, Hosseini SM, Kazemian S, et al.
    Molecular Epidemiology and Phylogenetic Analysis of HTLV-1 in HIV-1-infected Patients in Tehran, Iran.
    J Med Virol 2026;98:e71107.
    


15. Suwannakarn K, Chaimayo C, Boonmee A, Leeyaphan C, et al.
    Genomic Epidemiology and Clinical Characteristics of Mpox Lineage C.1 Outbreak in Thailand, 2023-2024.
    J Med Virol 2026;98:e71142.
    


16. Dlamini S, Ojwach D, Giandhari J, Ndlovu B, et al.
    Genetic divergence between reservoir and pre-therapy plasma HIV-1 Env variants does not confer consistent compartment-specific differences in broadly neutralizing antibody sensitivity.
    J Virol 2026.
    


17. Canepa HM, Medley A, Gutreuter S, Connolly H, et al.
    Validation of a National Pediatric HIV Risk Screening Tool at 31 Health Facilities in Zambia: Diagnostic Performance and Programmatic Implications, 2021-2022.
    Pediatr Infect Dis J 2026.
    


18. Mahase E.
    Lenacapavir: Gilead is urged to change price after NHS rejects HIV drug owing to cost.
    BMJ 2026;394:e100825.
    


19. Tsanni A.
    US plans to stop HIV support for Namibia as African country rejects "colonial" data sharing demands.
    BMJ 2026;394:e100827.
    

Display articles in

• Abstract format